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Research
Cancer stem cells (CSCs) are generally consid-
ered to be a minor tumor subpopulation but 
the driving force for tumor initiation, progres-
sion, and metastasis (Rosen and Jordan 2009). 
Initially detected in leukemia (Bonnet and Dick 
1997), CSCs have now been identified in other 
tumors and cell transformants based on surface 
markers, phenotypic traits indicative of malig-
nancy (such as xenograft tumor formation), 
and in vitro characteristics including matrix 
metalloproteinase (MMP) secretion, colony 
formation, and formation of nonadherent 
spheroids. (Tokar et al. 2010a; Visvader and 
Lindeman 2008). CSCs share characteristics 
with normal stem cells (NSCs), although CSCs 
show dysregulated self-renewal (Bomken et al. 
2010). The origin of CSCs and the mechanisms 
involved in their formation are incompletely 
defined. Recent studies indicate that CSCs may 
be derived from transformed NSCs (Iliopoulos 
et al. 2010; Wang 2010), although committed 
progenitors or even differentiated cells also may 
produce CSCs (Wang 2010).
Inorganic arsenic threatens millions of 
persons through contaminated drinking water 
[International Agency for Research on Cancer 
(IARC) 2011]. Arsenic is a human carcinogen 
(IARC 2011), and although underlying mecha-
nisms remain uncertain, it appears capable of 
both genotoxic and epigenetic mechanisms of 
initiation (Kojima et al. 2009). The prostate is 
considered a possible target of arsenic carcino-
genesis (IARC 2011). In mice, inorganic arse-
nic causes tumor development in the urogenital 
system (Waalkes et al. 2007). Accumulating 
evidence suggests that stem cells (SCs) likely 
play a key role in arsenic carcinogenesis. For 
example, human epidermal cells exposed to 
inorganic arsenic maintain a germinative state 
with altered SC dynamics (Patterson et al. 
2005). Chronic inorganic arsenic in vitro causes 
malignant transformation of the human pros-
tate epithelial cell line, RWPE-1 (also termed 
CAsE-PE cells) (Achanzar et al. 2002), and 
can similarly induce a malignant phenotype 
in an isogenic prostate NSC line, WPE-stem 
(Tokar et al. 2010a). Arsenic-transformed pros-
tate NSCs rapidly produce highly aggressive, 
immature and pluripotent tumors in mice, 
qualifying the transformed NSCs as CSCs 
(Tokar et al. 2010a). Furthermore, when the 
whole population of prostate epithelial cells is 
malignantly transformed by arsenic, it involves 
a survival selection for, and overproduction 
of, CSCs (Tokar et al. 2010b). Similarly, in a 
mouse carcinogenesis model, prenatal arsenic 
exposure distorts postnatal skin SC dynam-
ics, increases chemically induced formation of 
squamous cell carcinoma, and increases tumor 
CSC content relative to tumors induced with-
out prenatal arsenic exposure (Waalkes et al. 
2008). Interestingly, it has long been appreci-
ated that arsenic-induced cases of human skin 
cancer are typically multifocal (IARC 1973), 
potentially endowing multiple cells with tumor-
forming capacity (i.e., CSCs). Further, human 
skin keratinocytes malignantly transformed by 
inorganic arsenic in vitro show a clear over-
abundance of CSCs, even compared to trans-
formation by effective skin carcinogens like 
UV-irradiation (Sun et al. 2012). Likewise, 
arsenic-induced lung and liver tumors in mice 
show a clear CSC overabundance compared 
with spontaneous tumors and cancers induced 
by organic carcinogens (Tokar et al. 2011a). 
Thus, both in vivo and in vitro data indicate 
that inorganic arsenic produces a consistent 
CSC overabundance at the same time it causes 
acquisition of malignant phenotype.
Like NSCs, CSCs typically reside in a 
microenvironmental niche (Borovski et al. 
2011). Many microenvironmental factors 
influence tumor growth by modifying 
responses at the SC level. For instance, the 
growth potential of prostate CSCs is enhanced 
by their production of inflammatory cytokines 
including interluekin-6 (IL-6) (Liao et al. 
2010), which can stimulate or regulate CSCs 
through a variety of pathways (Korkaya et al. 
2011). Thus, the dynamic equilibrium between 
CSCs and more “differentiated” tumor cells is 
thought to be mediated, at least in part, by the 
microenvironment, including local cytokine 
secretion (Iliopoulos et al. 2010; Korkaya et al. 
2011; Liao et al. 2010).
Since malignant cells release various solu-
ble factors that modify tumor behavior, some 
of which also regulate CSCs (Iliopoulos et al. 
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Ba c k g r o u n d: Cancer stem cells (CSCs) are likely critical to carcinogenesis, and, like normal stem 
cells (NSCs), are affected by microenvironmental factors. Malignant cells release extracellular fac-
tors, modifying tumor behavior. Inorganic arsenic, a human carcinogen, is associated with an over-
production of CSCs in various model systems of carcinogenesis.
oB j e c t i v e: We aimed to determine if NSCs are influenced by nearby arsenic-transformed malig-
nant epithelial cells (MECs) as a possible factor in arsenic-associated CSC overabundance.
Me t h o d s : Transwell noncontact co-culture allowed the study of the effects of non-contiguous, 
arsenic-transformed prostate MECs on the isogenic human prostate NSC line, WPE-stem. Cancer 
phenotype was assessed by evaluating secreted matrix metalloproteinases (MMPs), invasiveness, 
colony formation, and spheroid formation. Gene expression was assessed at the protein (Western 
blot) or mRNA (real-time reverse transcription–polymerase chain reaction) levels.
re s u l t s: Noncontact co-culture of MECs and NSCs rapidly (≤ 3 weeks) caused hypersecretion of 
MMPs and marked suppression of the tumor suppressor gene PTEN in NSCs. NSCs co-cultured 
with MECs also showed increased invasiveness and clonogenicity and formed more free-floating 
spheroids and highly branched ductal-like structures in Matrigel, all typical for CSCs. MEC 
co-culture caused dysregulated self-renewal and differentiation-related gene expression patterns 
and epithelial-to-mesenchymal transition in NSCs consistent with an acquired cancer phenotype. 
Interleukin-6 (IL-6), a cytokine involved in tumor microenvironment control, was hypersecreted by 
MECs, and IL-6 exposure of NSCs resulted in the duplication of several responses in NSCs of con-
version to CSCs via MEC co-culture (e.g., MMP hypersecretion, decreased PTEN).
co n c l u s i o n s: Arsenic-transformed MECs recruit nearby NSCs into a cancer phenotype, thereby 
potentially increasing CSC number. This may be a factor in arsenic-induced CSC overabundance 
seen in multiple model systems.
key w o r d s : arsenic, cancer stem cells, interluekin-6, prostate, stem cells. Environ Health Perspect 
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2010; Korkaya et al. 2011; Liao et al. 2010), 
we suspected that malignant epithelial cells 
may affect non-contiguous NSCs. We hypoth-
esized that this could be a way in which arsenic 
induces overproduction of CSCs in tumors 
or induces multifocal tumors. Thus, using 
the prostate normal stem/progenitor cell line 
WPE-stem (henceforth referred to as NSCs) 
we assessed the impact of neighboring arsenic-
transformed malignant epithelial cells (MECs) 
on NSCs via noncontact co-culture. Our 
results indicate that the prostate MECs drive 
nearby NSCs into a cancer phenotype, in effect 
creating putative CSCs without any actual 
physical contact. This tumor “recruitment” of 
NSCs potentially constitutes a new phenom-
enon in cancer growth and dissemination, and 
could help account for the repeated observa-
tions of arsenic-induced CSC overabundance 
in tumors or malignantly transformed cells.
Materials and Methods
Cell lines and culture. All cell lines used in the 
present study are isogenic. The normal human 
prostatic epithelial cell line, RWPE-1, a gift 
from M. Webber (Michigan State University), 
is heterogeneous, containing stem/progeni-
tor, intermediate, and differentiated cell types 
(Tokar et al. 2005). The WPE-stem cell line 
(NSCs) was isolated from the RWPE-1 line by 
single-cell dilution cloning and shows charac-
teristics of urogenital system stem/progenitor 
cells, with anchorage-independent growth, 
nonadherent spheroid formation, high expres-
sion of p63, K5, K14, ABCG2, and BMI, 
and low expression of K8, K18, AR, and PSA 
(Tokar et al. 2005, 2010a). These NSCs also 
show self-renewal as evidenced by serial sphere 
passage capacity (data not shown). Arsenic 
malignantly transformed prostate epithelia 
(originally termed CAsE-PE cells; in this study 
termed MECs) were developed from RWPE-1 
cells chronically exposed to sodium arsenite 
(5 μM) and show multiple malignant pheno-
type characteristics, including hypersecretion 
of MMP-9, colony formation in agar, and 
aggressive xenograft malignancies (Achanzar 
et al. 2002; Tokar et al. 2010b).
To investigate potential effects of neigh-
boring cells on NSCs, NSCs were exposed 
to MECs or control RWPE-1 cells via a 
co-culture system (Corning Life Sciences, 
Suwanee, GA) that did not allow direct con-
tact between the two cell types. NSCs were 
seeded into the lower compartment of 6-well 
transwell plates. After 1 day to allow NSCs 
to attach, malignant or control epithelial cells 
were seeded on the transwell inserts (collagen-
coated 0.4-μm pore PTFE (polytetrafluoro-
ethylene) membrane). The cell layers were 
approximately 1 mm apart in this system. The 
MECs were derived as reported by Achanzar 
et al. (2002) and used for exposure to NSCs in 
the co-culture system. The MECs (about 3 mil-
lion cells) were first washed twice with 5 mL 
Dulbecco’s phosphate-buffered saline (DPBS) 
and lifted using 2 mL trypsin and 4 mL DPBS 
before adding in the insert (75,000 cells/insert). 
Direct evaluation of conditioned medium from 
MECs during co-culture (at 3 weeks) revealed 
no detectable arsenic above background by 
atomic absorption spectrophotometry.
Cell culture surfaces for SC were coated 
with type IV collagen (Trevigen, Gaithersburg, 
MD) and fibronectin (BD Biosciences, 
Bedford, MD) (2.5 μg of each/mL). Cells 
were maintained in low-calcium, serum-free 
medium [keratinocyte serum-free medium 
(KSFM)] containing 50 μg/mL bovine pitu-
itary extract, 5 ng/mL epidermal growth fac-
tor, and 1% antibiotic-antimycotic mixture 
(all from Gibco, Rockville, MD), to main-
tain the stem/progenitor cell phenotypic status 
(Litvinov et al. 2006). Cells were incubated at 
37°C in 5% CO2 with a medium change every 
48 hr and passaged weekly. Various assess-
ments were carried out weekly during 3 weeks 
of co-culture. Sphere assessment continued for 
an additional week, as it took 1 week for the 
spheres to form.
MMP activity. Secreted MMP activity is 
highly correlated with malignant transforma-
tion in the cells used in this study (Achanzar 
et al. 2002; Tokar et al. 2010a, 2010b). After 
co-culture with MECs, SC were re-plated and 
grown alone to collect conditioned medium, 
and secreted MMP-9 or MMP-2 activity was 
examined by zymography (Tokar et al. 2005).
Free-floating sphere formation. The for-
mation of free-floating spheres of viable cells 
is characteristic of NSCs and CSCs (Tokar 
et al. 2005, 2010b). Weekly during MEC 
co-culture, SC were collected by trypsin, 
filtered through a 40-μm cell strainer (BD 
Falcon, Franklin Lakes, NJ) to a single cell sus-
pension, and plated in uncoated 6-well plates. 
Cells were fed every 48 hr. After 1 week, float-
ing spheres and adherent cells were collected 
separately, and viable cells were quantitated by 
automated cell counter.
Anchorage-independent growth. Colony 
formation in soft agar from cells derived from 
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Figure 1. Secreted MMP activity, PTEN expression and invasiveness of NSCs during noncontact co-culture 
with prostate MECs or control RWPE-1 cells. (A) MMP-9 activity of NSCs during co-culture. Inset: repre-
sentative zymogram of secreted MMP-9 at 2 weeks. (B) MMP-2 activity of NSCs during co-culture. (C) 
Expression of PTEN in NSCs during co-culture. Inset: example of PTEN protein levels determined by 
Western blot at 2 weeks. (D) Invasion capacity of NSCs co-cultured after 3 weeks. Quantitative results are 
presented as mean ± SE; n = 3 except for invasion where n = 7. 
*p < 0.05, compared with time-matched control.Malignant epithelia transform normal stem cells
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free-floating spheres is related to the NSC or 
CSC phenotype (Stingl et al. 2006) and is 
indicative of anchorage-independent growth. 
After noncontact co-culture, floating spheroid 
cells were separated from adherent cells, and 
colony formation in soft agar was assessed 
(Tokar et al. 2005).
Branched ductal-like structures and serial 
passage. After 3 weeks of co-culture, single 
SC were seeded into uncoated 6-well plates 
until free-floating spheres formed. Free-
floating spheres were collected, dissociated 
by pipette trituration and filtered through a 
40-μm cell strainer. Cells were suspended in 
1:1 Matrigel/KSFM growth medium in a total 
volume of 200 μL, plated in a 24-well plate, 
and placed in the incubator overnight. The 
next day, 1 mL of KSFM growth medium was 
added on top of the solidified Matrigel mix-
ture. The medium was changed every 3 days. 
Photomicrographs were taken with an inverted 
microscope after 2 weeks. For serial passage (a 
measurement of self-renewal capacity typical 
of NSCs or CSCs), colonies in Matrigel were 
collected, disassociated into single cells, and 
re-plated into 24-well plates in the Matrigel 
mixture as described above. The formation of 
new colonies in Matrigel was accomplished at 
least 3 times.
Invasion. Invasive ability as a malignant 
phenotype was assessed using a modified 
Boyden chamber assay (Bello et al. 1997).
Assessment of gene expression. Transcript 
levels of p63, WNT3, OCT-4, NOTCH-1, 
K5, K18, PTEN, and E-CAD were examined 
by real-time reverse transcription–polymerase 
chain reaction (RT-PCR) as described pre-
viously (Tokar et al. 2010a). Cycle time 
(Ct) values were normalized based on con-
trol = 100% using the average values of 
β-actin (ACTB) and glyceraldehyde 3-phos-
phate dehydrogenase (GAPDH) from the 
same sample. Primer sequences are provided 
in Supplemental Material, Table 1 (http://
dx.doi.org/10.1289/ehp.1204987).
For Western blots, protein was col-
lected with M-PER Mammalian Protein 
Extraction Reagent (Pierce, Rockford, IL), 
containing 0.1 mM phenylmethyl sul-
fonyl fluoride (Sigma-Aldrich, St. Louis, 
MO) and 1% Protease Inhibitor Cocktail 
(Thermo Scientific, Rockford, IL). Western 
blots were performed as described previously 
(Tokar et al. 2010b). Protein bands were 
assessed by ECL Reagent (GE Healthcare, 
Buckinghamshire, UK).
Immunofluorescence. NSCs co-cultured 
with MECs were washed with DPBS and 
fixed with acetone and methanol (1:1, vol:vol). 
For staining, cells were blocked with normal 
horse serum (room temperature, 1 hr), incu-
bated with primary antibodies [rabbit anti-K5 
(ABcam, Cambridge, MA), mouse anti-p63 
(Santa Cruz Biotechnology, Santa Cruz, CA) 
or mouse anti-VIMENTIN (Sigma-Aldrich)], 
at 4°C, overnight, rinsed, incubated at room 
temperature for 1 hr with secondary anti-
bodies labeled with Alexa Fluor 488 or 568 
(Molecular Probes, Eugene, OR), and rinsed 
again. Cells were also stained with DAPI (4´,6-
diamidino-2-phenylindole dihydrochloride) 
(Invitrogen, Eugene, OR) at room tempera-
ture for 10 min. After washing with DPBS, 
photomicrographs were captured with an 
automated Olympus inverted fluorescence 
microscope, equipped with a 40× objective 
(Olympus Corporation, Center Valley, PA). 
Photomicrographs were processed by CellSens 
software (Olympus Corporation) with con-
sistent settings (e.g., exposure time) for both 
control and MEC groups.
IL-6 assessment and treatment. Using 
normal culture conditions, IL-6 secreted into 
culture medium by MECs over 24 hr was 
determined using the human IL-6 ELISA kit 
(R&D Systems, Minneapolis, MN). NSCs 
treated with 20 ng/mL IL-6 for 1 week were 
analyzed for characteristics indicative of can-
cer phenotype such as MMP-9 activity and 
expression of K5, p63, PTEN, E-CADHERIN 
(E-CAD) and VIMENTIN.
Statistical analysis. Data represent means 
and standard errors (SE). Student’s t-test was 
used in all comparisons, with a p < 0.05 con-
sidered significant.
Results
Noncontact MEC co-culture and NSCs trans-
formation. Secreted MMP activity is strongly 
associated with malignant transformation for 
the cells used in this study. Indeed, after only 
2 weeks of noncontact co-culture with MECs, 
NSCs showed hypersecretion of MMP-9, 
and by 3 weeks also showed hypersecretion 
of MMP-2 (Figure 1A, B). NCSs co-cultured 
with MECs showed maximal secreted MMP-9 
activity of 3.6 times control and maximal 
MMP-2 activity of 3.5 times control. Cells 
isogenic with the NSCs and MECs used in 
this work showing increased secreted MMP-9 
activity in the range of 2.0 to 4.5 times con-
trol consistently produce malignant tumors 
upon inoculation into mice (Achanzar et al. 
2002; Tokar et al. 2010b). PTEN, a tumor 
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Figure 2. Assessment of acquired cancer phenotype in NSCs noncontact co-cultured with MECs or control 
RWPE-1 cells. (A) Viable floating nonadherent spheroids from NSCs after co-culture. Inset: free-floating 
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suppressor gene that plays a critical role in 
SC differentiation and is often inactivated 
in malignancies, was rapidly and persistently 
suppressed in NSCs with MEC co-culture 
at both the transcriptional (Figure 1C) and 
translational (Figure 1C inset) levels. Invasive 
capacity in NSCs also increased after MEC 
co-culture (Figure 1D).
Nonadherent spheroid-forming abil-
ity is a common characteristic of NSCs and 
CSCs. Thus, sphere-forming capacity and the 
CSC-like phenotype of free-floating spheres 
were assessed after noncontact co-culture. By 
4 weeks, the number of viable free-floating 
spheres produced by SCs after MEC 
co-culture was 4 times the number produced 
after control co-culture (Figure 2A). Secreted 
MMP activity of the spheroid SCs formed 
by noncontact MEC co-culture also mark-
edly increased relative to the MMP activity 
of spheroid SCs formed after co-culture with 
control cells (Figure 2B). Colony formation 
of spheroid cells in soft agar, an indication 
of anchorage-independent growth common 
to cancer cells, was markedly increased in 
spheroid cells produced by MEC (vs. con-
trol) co-culture (Figure 2C). After 3 weeks of 
MEC co-culture, single SCs formed spheres 
with a highly branched ductal-like structure in 
Matrigel (Figure 2D; bottom) indicative of an 
aggressive phenotype. The spheres formed in 
Matrigel from NSCs co-cultured with control 
cells showed minimal branching (Figure 2D; 
top). Cells from the structures formed in 
Matrigel after MEC co-culture could be serial 
passaged (≥ 3 times), indicative of the self-
renewal capacity typical of CSCs.
SC-related gene expression and epitheli-
al-to-mesenchymal transition (EMT) with 
co-culture. The prostate SC-associated genes 
NOTCH-1, OCT-4, BMI-1, and p63 all 
showed an early transcription expression loss 
in SCs during the first 2 weeks of noncontact 
co-culture with MECs (Figure 3A–3D). By 
3 weeks of MEC co-culture, these genes were 
reactivated in SCs to levels at or near control. 
WNT signaling activation, which is consid-
ered a functional marker of CSCs (Vermeulen 
et al. 2010), showed a similar “U-shaped” 
expression pattern in SCs over 3 weeks of 
MEC co-culture [see Supplemental Material, 
Figure 1A (http://dx.doi.org/10.1289/
ehp.1204987)]. In addition, K5, a marker of 
undifferentiated prostate SCs, also showed loss 
followed by reactivation in SCs co-cultured 
with MECs (see Supplemental Material, 
Figure 1B). K18, a marker of cellular differ-
entiation showed an opposite expression trend 
(see Supplemental Material, Figure 1C). EMT 
of SCs occurs as early stage tumors are con-
verted into invasive cancers, and is a critical 
mechanism for acquisition of metastatic capac-
ity (Kang and Massague 2004). After 3 weeks 
of MEC co-culture, SCs exhibited depolar-
ized spindle-like morphology (Figure 3E), 
increased VIMENTIN expression (Figure 3F) 
and decreased E-CAD expression (Figure 3G 
and 3H), all indicative of EMT. Normally, the 
NSCs used in this study show homogeneous 
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Figure 3. Expression of genes associated with SC self-renewal and maintenance, and signs of EMT after noncontact co-culture with MECs or control RWPE-1 
cells. Transcript levels of NOTCH-1 (A), OCT-4 (B), BMI-1 (C), and p63 (D). The morphologic alteration of NSCs (bar = 200 μm; E), the hyper-expression of 
VIMENTIN (bar = 20 μm; F), and the decrease in E-CAD transcript (G), and protein expression (bar = 20 μm; H) indicative of EMT of SCs after co-culture with MECs 
for 3 weeks. NSCs after co-culture with control epithelial cells are shown in insets for (E) and (F) for comparison. Results are mean ± SE (n = 3). 
*p < 0.05, compared with time-matched control.Malignant epithelia transform normal stem cells
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K5 and p63 expression. When NSCs were 
co-cultured with MECs, K5 and p63 pro-
tein levels decreased homogeneously across all 
cells by 2 weeks, but increased and returned 
to control levels by 3 weeks (Figure 4), consis-
tent with the patterns observed for transcript 
levels (Figure 3 and Supplemental Material, 
Figure 1). These results were qualitatively con-
firmed by Western blot (not shown).
IL-6 and acquired cancer phenotype in 
NSCs. Over a 24-hour period using normal cul-
ture conditions, MECs cultured alone secreted 
2.8 times more IL-6 than control epithelial cells 
(Figure 5A). Furthermore, after only 1 week 
of IL-6 treatment, NSCs showed a 350% 
increase in MMP-9 secretion relative to controls 
(Figure 5B), and a marked increase in p63 and 
K5 expression (Figure 5C), while PTEN and 
E-CAD expression decreased (Figure 5D). The 
marked elevation of VIMENTIN expression 
in IL-6-treated NSCs compared with control 
(Figure 5E and 5F) provides molecular evidence 
of EMT after IL-6 exposure. These results indi-
cate NSCs rapidly acquire a cancer-like phe-
notype after IL-6 exposure that is similar in 
nature to the phenotype acquired after NSCs 
are co-cultured with MECs.
Discussion
Arsenic is a human carcinogen, and the pros-
tate is a potential target organ (IARC 2011). 
We have shown direct arsenic exposure trans-
forms human prostate NSCs into CSCs more 
rapidly (18 weeks) (Tokar et al. 2010a) than 
their heterogeneous parental epithelial pros-
tate cells (RWPE-1 cells) are transformed into 
MECs (29 weeks) (Achanzar et al. 2002). In 
the present study, the NSC line was very rap-
idly pushed towards a CSC-like phenotype by 
nearby MECs previously transformed by arse-
nic. Temporally, this is consistent with CSCs 
being capable of initiating malignant growth. 
Because the co-culture system did not con-
tain arsenic or allow physical contact between 
NSCs and MECs, this transformation was 
likely due to factors secreted by the MECs. 
The distance between the MECs and NSCs in 
this co-culture system (1 mm) is comparable 
to the width of about 100 prostate epithe-
lial cells. This phenomenon may constitute 
a novel “recruitment” by arsenic-produced 
malignant prostate epithelial cells of nearby 
prostate NSCs into putative CSCs that could 
affect tumor growth, invasion, dissemination, 
or field cancerization. As such, this suggests 
a potentially important aspect of arsenic car-
cinogenesis that may help explain why arsenic 
causes CSC overabundance in various in vivo 
and in vitro model systems of carcinogenesis 
(Achanzar et al. 2002; Sun et al. 2012; Tokar 
et al. 2010b, 2011b; Waalkes et al. 2008). It 
will be very interesting to see if MECs origi-
nally transformed by other carcinogens can 
similarly recruit NSCs into CSCs.
The PTEN tumor suppressor gene is 
frequently mutated, deleted, or inactivated 
in prostate cancers (Verhagen et al. 2006). 
During MEC co-culture, SC PTEN was 
rapidly and persistently suppressed as the 
oncogenic phenotype was acquired. PTEN 
inactivation appears important for the early 
selection and expansion of SCs during malig-
nant transformation (Verhagen et al. 2006). 
The loss of PTEN activity enhances cell pro-
liferation, decreases apoptosis, and leads to the 
expansion of prostatic CSC-like cells, tumor 
initiation, and metastasis (Wang et al. 2006). 
For prostate SCs, PTEN knockout increases 
CSC-like sphere formation capacity and tum-
origenic potential (Dubrovska et al. 2009). 
Thus, the suppression of PTEN expression in 
this study strongly supports the notion that 
Control  co-culture
MEC co-culture—2 weeks
MEC co-culture—3 weeks
p63 p63 + K5 K5 DAPI
Figure 4. Fluorescence microscopic imaging of protein expression levels of K5 (green) and p63 (red) in NSCs after noncontact co-culture with MECs or control 
RWPE-1 cells for 2 or 3 weeks (bar = 20 μm). Both K5 and p63 decreased after 2 weeks of co-culture with MECs, but returned to control levels after 3 weeks. 
Control protein levels are shown for 2 weeks of exposure of NSCs to control epithelial cells and show similar expression at 0, 1, or 3 weeks. DAPI (blue) is a gen-
eral nuclear stain used to indicate cell number.Xu et al.
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prostatic SCs were transformed to a CSC-like 
phenotype by MEC co-culture.
Dysregulated self-renewal programming 
of CSCs is typical during oncogenesis (Pardal 
et al. 2003). During MEC co-culture, an early 
loss and subsequent reactivation of various 
SC self-renewal genes, such as NOTCH-1, 
OCT-4, BMI-1, p63, and WNT3 occurred. 
NOTCH-1 is a prostate SC marker that can 
act as both an oncogene and tumor suppres-
sor gene in tumors (Leong and Gao 2008). 
OCT-4 regulates self-renewal in SCs, and 
is potentially involved in the maintenance 
of CSC-like properties (Hochedlinger et al. 
2005). BMI-1 is crucial to both NSCs and 
CSCs (Lessard and Sauvageau 2003) and, in 
prostate cancer, is an essential regulator of 
SC renewal and tumor initiation and pro-
gression (Lukacs et al. 2010). The WNT 
pathway regulates NSC self-renewal, and 
hyperactivation is linked to carcinogenesis 
(Vermeulen et al. 2010). p63 is required for 
self-renewal and proliferative capacity of pros-
tate SCs (Senoo et al. 2007) and promotes 
neoplastic growth (Nylander et al. 2002). 
The time-related, decreased-then-increased, 
gene expression pattern during acquisition 
of oncogenic characteristics in SCs seen in 
our study is consistent with the expression of 
SC-related genes observed in NSCs during 
arsenic-induced malignant transformation 
(Tokar et al. 2010a). Indeed, when NSCs 
were malignantly transformed by direct arse-
nic exposure, the expression of various critical 
SC self-renewal and differentiation genes was 
first lost and then regained as cells acquired 
a malignant phenotype (Tokar et al. 2010a). 
This pattern of SC-related gene response is 
also consistent with that observed during 
transformation of hematopoietic SCs into leu-
kemic SCs (Krivtsov et al. 2006; Somervaille 
and Cleary 2006). Inappropriate activation 
of the embryonic SC-like transcriptional 
program appears to induce CSCs in adult 
epithelial cells (Wong et al. 2008). Thus, 
the distorted expression of SC-related genes 
observed in this study is likely an important 
feature of CSC formation. In addition, K5 
and K18, markers for undifferentiated and 
differentiated epithelia, respectively (Schalken 
and van Leenders 2003), showed opposing 
expression patterns (i.e., K5, loss and regain; 
K18, increase and then loss), fortifying the 
notion of initial dysregulation of SC charac-
teristics during “recruitment” and subsequent 
transformation by nearby MECs into CSCs.
The fate of CSCs is dynamically orches-
trated by their microenvironment (Liao et al. 
2010; Suzuki et al. 2011). Secreted extracellu-
lar matrix degradation factors, growth factors, 
and cytokines can facilitate tumor progression 
and enhance malignant characteristics of CSCs 
(Liao et al. 2010; Suzuki et al. 2011). IL-6, 
a pleiotrophic inflammatory cytokine, is ele-
vated in the serum of prostate cancer patients 
and related to progression and metastases in 
prostate cancers (Azevedo et al. 2011). In vitro 
IL-6 induces malignant conversion of benign 
prostate epithelia (Rojas et al. 2011), although 
the role of SCs in this process is unknown. 
In breast cancer cell lines, IL-6 converts non-
stem cancer cells into CSCs (Iliopoulos et al. 
2010). Although many agents cause IL-6 to 
be secreted, the overexpression or hyperse-
cretion of IL-6 can be induced by arsenic 
exposure both in vivo (Das et al. 2005) and 
in vitro (Lee et al. 2005). In the present work, 
prostate MECs under normal culture con-
ditions secreted high levels of IL-6, consis-
tent with stimulation of autocrine IL-6 loops, 
conferring oncogenic properties (Rojas et al. 
2011). Furthermore, direct IL-6 treatment of 
NSCs led to oncogenic alterations (e.g., MMP 
hypersecretion, loss of PTEN) similar to those 
seen when NSCs underwent noncontact MEC 
co-culture. These results suggest that IL-6 may 
facilitate transformation of NSCs to CSCs 
during noncontact MEC co-culture.
Conclusions 
These data support the concept that NSCs 
can be driven towards a CSC phenotype as 
a key aspect of arsenic-induced oncogen-
esis. Furthermore, at least with prostate cells, 
“recruitment” appears to occur where arsenic-
transformed MECs send out signals, potentially 
including IL-6, which can convert NSCs into 
CSC-like cells over a significant distance. This 
recruitment by cancer cells of NSCs into puta-
tive CSCs may facilitate tumor growth and dis-
semination and may help explain the repeated 
observation of CSC overabundance induced by 
arsenic in model systems of carcinogenesis.
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